drugset / Trial / NCT02356965
Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction
Phase 2
Completed
80 enrolled
iX Biopharma Ltd.
Jean Brown Research · collabLotus Clinical Research, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to test two different doses of ketamine sub-lingual (under the tongue) wafer against placebo to see how effective the medication is to treat moderate to severe pain after wisdom tooth extraction.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 70 mg | Other |
| Subject | Ketamine | Small molecule | 100 mg | Other |
Indications
No indication recorded.